Sunho Biologics, Inc. (HKG:2898)
6.39
0.00 (0.00%)
At close: Mar 31, 2026
Sunho Biologics Market Cap
Sunho Biologics has a market cap or net worth of 970.43 million as of October 9, 2026. It is the 23,995th most valuable company in the world and the 1,143rd biggest in Hong Kong. Its market cap has increased by 51.19% in one year.
Market Cap
970.43M
Enterprise Value
596.44M
Revenue
18.63K
Global Rank
Country Rank
#1,143 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since May 24, 2024, Sunho Biologics's market cap has decreased from 2.19B to 970.43M, a decrease of -55.64%. That is a compound annual growth rate of -35.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 970.43M | -3.77% |
| Dec 31, 2025 | 1.01B | 78.00% |
| Dec 31, 2024 | 566.51M | -74.10% |
| May 24, 2024 | 2.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SinoMab BioScience | 1.59B |
| TYK Medicines | 1.36B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.35B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.34B |
| Zhaoke Ophthalmology | 1.24B |
| JW (Cayman) Therapeutics Co. | 1.15B |
| CANbridge Pharmaceuticals | 1.14B |
| Cloudbreak Pharma | 1.10B |